| UniProt ID | GNT2A_HUMAN | |
|---|---|---|
| UniProt AC | Q8N0V5 | |
| Protein Name | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase {ECO:0000305} | |
| Gene Name | GCNT2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 402 | |
| Subcellular Localization |
Golgi apparatus membrane Single-pass type II membrane protein. |
|
| Protein Description | Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells.; Isoform C: Determines the expression of the blood group I antigen in erythrocytes.. | |
| Protein Sequence | MMGSWKHCLFSASLISALIFVFVYNTELWENKRFLRAALSNASLLAEACHQIFEGKVFYPTENALKTTLDEATCYEYMVRSHYVTETLSEEEAGFPLAYTVTIHKDFGTFERLFRAIYMPQNVYCVHLDQKATDAFKGAVKQLLSCFPNAFLASKKESVVYGGISRLQADLNCLEDLVASEVPWKYVINTCGQDFPLKTNREIVQYLKGFKGKNITPGVLPPDHAVGRTKYVHQELLNHKNSYVIKTTKLKTPPPHDMVIYFGTAYVALTRDFANFVLQDQLALDLLSWSKDTYSPDEHFWVTLNRIPGVPGSMPNASWTGNLRAIKWSDMEDRHGGCHGHYVHGICIYGNGDLKWLVNSPSLFANKFELNTYPLTVECLELRHRERTLNQSETAIQPSWYF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 (in isoform 2) | Phosphorylation | - | 18.30 | - | |
| 4 | Phosphorylation | ----MMGSWKHCLFS ----CCCCHHHHHHH | 18.30 | - | |
| 28 (in isoform 3) | Phosphorylation | - | 7.00 | 24719451 | |
| 41 | N-linked_Glycosylation | FLRAALSNASLLAEA HHHHHHHCHHHHHHH | 34.10 | UniProtKB CARBOHYD | |
| 61 | O-linked_Glycosylation | EGKVFYPTENALKTT CCCCCCCCHHHHCCC | 30.41 | OGP | |
| 83 | Phosphorylation | EYMVRSHYVTETLSE HHHHHHHCCEECCCH | 15.43 | 30576142 | |
| 85 | Phosphorylation | MVRSHYVTETLSEEE HHHHHCCEECCCHHH | 18.98 | 30576142 | |
| 145 | Phosphorylation | GAVKQLLSCFPNAFL HHHHHHHHHCCCHHH | 23.46 | 20873877 | |
| 154 | Phosphorylation | FPNAFLASKKESVVY CCCHHHHCCCHHHHC | 46.54 | 20873877 | |
| 198 | Ubiquitination | CGQDFPLKTNREIVQ CCCCCCCCCHHHHHH | 43.95 | 29967540 | |
| 199 | Phosphorylation | GQDFPLKTNREIVQY CCCCCCCCHHHHHHH | 47.38 | 24719451 | |
| 206 | Phosphorylation | TNREIVQYLKGFKGK CHHHHHHHHHCCCCC | 10.25 | 24719451 | |
| 230 | Ubiquitination | DHAVGRTKYVHQELL CCCCCCHHHHHHHHH | 43.87 | 29967540 | |
| 240 | Ubiquitination | HQELLNHKNSYVIKT HHHHHCCCCCEEEEE | 46.66 | 29967540 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GNT2A_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GNT2A_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GNT2A_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| AT2A1_HUMAN | ATP2A1 | physical | 26186194 | |
| METL9_HUMAN | METTL9 | physical | 26186194 | |
| GHITM_HUMAN | GHITM | physical | 26186194 | |
| COEA1_HUMAN | COL14A1 | physical | 26186194 | |
| TRI68_HUMAN | TRIM68 | physical | 26186194 | |
| FAM3C_HUMAN | FAM3C | physical | 26186194 | |
| DPB1_HUMAN | HLA-DPB1 | physical | 26186194 | |
| TRI68_HUMAN | TRIM68 | physical | 28514442 | |
| AT2A1_HUMAN | ATP2A1 | physical | 28514442 | |
| GHITM_HUMAN | GHITM | physical | 28514442 | |
| COEA1_HUMAN | COL14A1 | physical | 28514442 | |
| FAM3C_HUMAN | FAM3C | physical | 28514442 | |
| DPB1_HUMAN | HLA-DPB1 | physical | 28514442 | |
| METL9_HUMAN | METTL9 | physical | 28514442 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...